IFFIm Board of Directors attend key meetings with Gavi, World Bank in Washington, DC to bolster support for Gavi’s 6.0 strategy and prepare for bond transaction
IFFIm Board of Directors attend key meetings with Gavi, World Bank in Washington, DC to bolster support for Gavi’s 6.0 strategy and prepare for bond transaction
14 November 2024
The IFFIm Board
At an 8 October event at the World Bank, IFFIm’s Board and the Gavi IFFIm-focused Secretariat team met with Gavi’s Audit and Finance Committee (AFC) to provide a technical briefing on IFFIm, its partnership with the World Bank and evolving role in partnership with Gavi.
IFFIm's Board of Directors gathered in Washington, DC in October for their quarterly meeting as well as various meetings with stakeholders.
On 8 October at the World Bank, IFFIm’s Board and the Gavi IFFIm-focused Secretariat team met with Gavi’s Audit and Finance Committee (AFC) and CEO, Dr Sania Nishtar, to provide a technical briefing on IFFIm, its partnership with the World Bank and the evolving partnership between IFFIm and Gavi. The discussion not only emphasised IFFIm’s critical contributions and impact, especially in light of Gavi’s 6.0 replenishment strategy, but also reflected the significance of IFFIm to Gavi’s mission and upcoming strategic cycle.
On 10 October, IFFIm’s Board of Directors gathered at Gavi’s Washington, DC offices to strengthen their support for Gavi’s upcoming replenishment and strategic goals for 2025 and beyond.
The Board focused on an upcoming bond issuance, a comprehensive report on donor relations and communications in the context of positioning IFFIm as a crucial financial partner in Gavi’s replenishment efforts, aiming to maximise its impact for Gavi's 6.0 strategy. Working in close collaboration with the Gavi Secretariat and the World Bank, IFFIm is committed to maintaining its vital role in funding Gavi's life-saving vaccination programs.
In addition to welcoming Eila Kreivi and Rachel Turner to their first meeting, the IFFIm Board also appointed Jeff Diehl as the newest board member, with a term extending through 2027. Diehl’s expertise and leadership will be instrumental as IFFIm navigates the challenges and opportunities associated with supporting global immunisation efforts.
The next IFFIm Board meeting will be held virtually in December.
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.
Reflections on IFFIm: an interview with Rachel Turner
14 November 2024